Urgent.News

What's breaking now, across thousands of outlets.

World

(EDITORIAL from Korea Times on Sept. 9)

Constitutional reform has come to the fore of Korean politics, as many point to ...

The ruling Democratic Party of Korea (DPK) is pushing for a constitutional revision in the first time in 39 years, as the current system has come under scrutiny for its impact on policy continuity and long-term leadership. President Lee Jae Myung, through his party's new leader Kim Min-seok, has stated that the party will pursue constitutional reform that is both achievable and reflective of the changing times, while respecting the principles of the Constitution and the law.

However, any amendment extending a presidential term or allowing for reelection will not apply to the incumbent president under Article 128 of the Constitution. This means President Lee will not be able to seek a second term if the Constitution is amended during his term. Although the DPK holds a majority in the National Assembly, they still need the support of other parties and the electorate to achieve the necessary two-thirds majority for the amendment.

The main opposition People Power Party (PPP) has expressed its opposition to any constitutional changes led by the Lee administration. The PPP's leader, Rep. Jeong Jeom-sig, stated that the party will not participate in the constitutional amendment process with the current administration. Meanwhile, National Assembly Speaker Cho Jeong-sik has raised concerns about ambiguous statements on the matter, which could contribute to political uncertainty.

The president faces a declining approval rating, with support for him and the ruling party slipping into the 30 percent range. To advance this constitutional amendment initiative, Lee must assure the public that he has no intention of seeking a second term, as any such move would be in contradiction to the Constitution they currently uphold.

Written by urgent.news from Yonhap News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Also reported by 1 other outlet

Read the original at en.yna.co.kr →

More in World

(EDITORIAL from Korea JoongAng Daily on Sept. 9)

Reinvestigate lobbying, stock manipulation claims : Authorities must swiftly inv...

  • Recordings show broker Yang contacted ruling-party figures for Genencell trial approval.
  • Sejong Medical invested 11.3 billion won in Genencell before trial approval in October 2021.

More from Tuesday 8 September →